CD3 Engagement as a New Strategy for Allogeneic “Off-the-Shelf” T Cell Therapy

By
Justin.choi
-
0
66
Bi-specific T cell engager (BiTE-T) cells down-regulated CD3ε/TCRαβ on bystander T cells by releasing BiTEs.
[Molecular Therapy-Oncolytics]

Sorry, but the selected Zotpress account can't be found.

Abstract